AzTrials
AzTrials

Upper Limb Amputation Below ElbowEMPOWERNCT07071584

Evaluation of a Multi-electrode Prosthesis Control System for Real-world Tasks Performance in Individuals With Upper Limb Transradial Amputation

A study of Upper Limb Amputation Below Elbow, run by Phantom Neuro Inc. at 2 sites in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study tests how well the Phantom X prosthesis control system works. The system helps control a prosthetic hand using muscle signals from the arm. You'll wear a non-invasive version for one day in the clinic. Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Upper Limb Amputation Below Elbow
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
2 sitesUnited States
Study dates
15 Aug 2025to Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals 21 years in age and older
  • Individuals with unilateral or bilateral amputation at transradial level
  • Patient is willing to comply with study protocol and make required study visits
  • Willingness and ability to sign Informed Consent

Who cannot join

  • Cognitively impaired to follow study instructions
  • Allergies to skin adhesive materials necessary for cutaneous electrode placement
  • Excessive hair growth on arms and inability to shave off the hair for electrode placement
  • Pregnant woman
  • Residual limbs of insufficient diameter or length to accommodate the wearing of two cutaneous sensor arrays
  • Injuries, bruises, or open wounds on the arm that needs to be instrumented for the study

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Phantom Neuro Inc. Operational Headquarters

    Austin, Texas, 78701

  • Atlas Ambulatory Surgery Center

    Buffalo, New York, 14221

Other trials in United States

About this study

Official title: Evaluation of a Multi-electrode Prosthesis Control System for Real-World Tasks Performance

This study tests how well the Phantom X prosthesis control system works. The system helps control a prosthetic hand using muscle signals from the arm. You'll wear a non-invasive version for one day in the clinic. You'll practice hand movements and then do two simple tasks with both your usual prosthesis and the Phantom X system. At the end, you'll fill out short surveys about your experience.

Read the detailed description

The goal of this study is to evaluate the functional performance of the Phantom X prosthesis control system using a non-invasive version of its 32-electrode sensor array. All other components, including the Fusion Port, will be in their final clinical form factor, consistent with those used in future implantable configurations. The study will take place during a single, in-clinic session. Informed consent will be obtained either remotely prior to the visit or at the start of the session. Participants will undergo an initial EMG screening to determine signal suitability. Those with insufficient signal quality will be excluded. Eligible participants will be fitted with a universal socket, prosthesis, and the Phantom X system. Accelerometers will be placed on both limbs for movement tracking. Participants will practice a predefined set of gestures, followed by system calibration. Two validated functional assessments, Assessment of Capacity for Myoelectric Control (ACMC) and Targeted Box and Blocks Test (tBBT), will be conducted under two conditions: with the participant's baseline setup (if applicable) and with Phantom X. The testing order will be randomized. Participants will complete a user satisfaction questionnaire and NASA Task Load Index instrument to measure intuitiveness of Phantom X system before exiting the study.

Being tested
Cutaneous Prosthesis Control System
Keywords
Myoelectric control, Transradial amputee, Prosthesis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cutaneous Prosthesis Control SystemDevice

    Prosthesis control system using a multi-electrode cutaneous sensor array

Study groups in NCT07071584
Study groupRoleWhat they receive
Participants instrumented with cutaneous version of Phantom X system using a universal socketExperimentalWith Phantom X system instrumented, participants will perform the following two assessments: ACMC and tBBT. They will also complete user satisfaction and NASA-TLX questionaries.
Receives: Device: Cutaneous Prosthesis Control System

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of Phantom X Prosthesis Control System in performing activities of daily living (ADL)

    Feasibility of prosthesis control will be assessed using Assessment of Capacity of Myoelectric Control (ACMC) and while participants perform predefined ADL tasks. ACMC score ranges from 0-100, higher score suggesting better prosthesis myoelectric control.

    Measured: Through study completion, average of 1 day

  2. Feasibility of Phantom X Prosthesis Control System in performing repeated task requiring hand dexterity

    Feasibility of Phantom X system in performing repeated task requiring prosthetic hand's dexterity will be assessed using Targeted Box and Blocks Test (tBBT) in which participants will transfer numbered blocks from one compartment to corresponding spots in a second adjacent compartment. tBBT is scored by measuring time taken to complete block transfer from one compartment to another. Lower completion time suggests better performance.

    Measured: Through study completion, average of 1 day

Secondary outcomes (2)
  1. Satisfaction of prosthesis control with Phantom X system

    Participant satisfaction in using the Phantom X control system will be collected using a questionnaire

    Measured: Through study completion, average of 1 day

  2. Intuitiveness of prosthesis control using Phantom X system

    Intuitiveness of prosthesis control with Phantom X control system will be evaluated using NASA-Task Load Index instrument (NASA-TLX)

    Measured: Through study completion, average of 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2025
  2. Study start15 Aug 2025
  3. Primary completionApr 2026 (estimated)
  4. Study completionJun 2026 (estimated)

Why it stopped: The study was stopped because of recruitment challenges and sponsor's decision to pivot to a new study outside the US

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07071584
Sponsor's protocol ID
PN02
Acronym
EMPOWER
Status last verified
Dec 2025
First submitted
19 Jun 2025
Last updated
13 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study of Upper Limb Amputation Below Elbow, run by Phantom Neuro Inc. at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of Phantom X Prosthesis Control System in performing activities of daily living (ADL) (time frame: Through study completion, average of 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in